ロード中...

Hexamethylene bisacetamide impairs NK cell-mediated clearance of acute T lymphoblastic leukemia cells and HIV-1-infected T cells that exit viral latency

The hexamethylene bisacetamide (HMBA) anticancer drug was dismissed due to limited efficacy in leukemic patients but it may re-enter into the clinics in HIV-1 eradication strategies because of its recently disclosed capacity to reactivate latent virus. Here, we investigated the impact of HMBA on the...

詳細記述

保存先:
書誌詳細
出版年:Sci Rep
主要な著者: Giuliani, Erica, Desimio, Maria Giovanna, Doria, Margherita
フォーマット: Artigo
言語:Inglês
出版事項: Nature Publishing Group UK 2019
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6416400/
https://ncbi.nlm.nih.gov/pubmed/30867508
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-019-40760-x
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!